Glenn John
CIK 0001253497
Chief Financial Officer
Filings
14
Latest Mar 5, 2026
Issuers covered
2
Showing
14 of 14
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 20% | -1.1% | -0.5% | +10.6% | -12.9% |
| 90 days | 5 | 40% | +4.4% | -3.5% | +39.6% | -11.5% |
| 180 days | 3 | 67% | +7.5% | +2.0% | +27.7% | -7.3% |
| 365 days | 2 | 50% | -10.6% | -10.6% | +49.8% | -71.0% |
Issuers
Companies where Glenn John has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IRMD | Iradimed Corp | 12 | Mar 5, 2026 |
| EKSO | Ekso Bionics Holdings, Inc. | 2 | Mar 28, 2022 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|